Volume 38 Issue 4
Apr.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2022  >  38(4): 308-314
KONG Jun-hong, CHEN Xuan, SHA Chen-xi, GONG Chu-qiao, SONG Xiao-long. Study on the Mechanism of Tanshinone ⅡA against Coronary Heart Disease with Comorbid Depression in ApoE-/- Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(4): 308-314. doi: 10.14148/j.issn.1672-0482.2022.0308
Citation: KONG Jun-hong, CHEN Xuan, SHA Chen-xi, GONG Chu-qiao, SONG Xiao-long. Study on the Mechanism of Tanshinone ⅡA against Coronary Heart Disease with Comorbid Depression in ApoE-/- Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(4): 308-314. doi: 10.14148/j.issn.1672-0482.2022.0308
shu

Study on the Mechanism of Tanshinone ⅡA against Coronary Heart Disease with Comorbid Depression in ApoE-/- Mice

doi: 10.14148/j.issn.1672-0482.2022.0308
  • 1.

    Changzhou Hospital of TCM Affiliated to Nanjing University of Chinese Medicine, Changzhou 213003, China

  • 2.

    Department of Cardiology, Yancheng Hospital of Traditional Chinese Medicine, Yancheng 224001, China

  • Received Date: 2021-10-21
    Available Online: 2022-04-13
    Abstract
  •   OBJECTIVE  To investigate the effect and mechanism of tanshinone ⅡA against coronary heart disease with comorbid depression in ApoE-/- mice.  METHODS  The model of coronary heart disease with comorbid depression was established by feeding high fat diet and carrying out chronic unpredictable mild stress (CUMS). Mice were randomly divided into normal group, model group, tanshinone ⅡA low dose group (30 mg · kg-1) and tanshinone ⅡA high dose group (60 mg · kg-1). Hematoxylin-eosin (HE) and oil red O staining were used to detect the pathological changes of cardiac aortic sinus in ApoE-/- mice. Forced swimming test (FST), tail suspension test (TST) and sucrose preference test (SPT) were used to observe the depression-like behaviors of ApoE-/- mice. The levels of blood lipid and inflammatory factors were detected by ELISA assay. The expressions of inflammation related proteins in cardiac aortic sinus and hippocampus were detected by Western blot.  RESULTS  Compared with the normal group, the lipid accumulation in the cardiac aortic intima in the model group increased significantly, the levels of blood lipid and pro-inflammatory factors increased significantly (P < 0.01), the immobility time of FST and TST significantly increased (P < 0.01), while the sucrose preference rate of SPT significantly decreased (P < 0.01), the ratios of p-GSK3β (Ser9)/GSK3β, p-NF-κB/NF-κB and p-CREB (Ser133)/CREB in cardiac aortic sinus and hippocampus increased significantly (P < 0.01). Compared with the model group, the treatment with tanshinone ⅡA significantly reduced the accumulation of lipid in cardiac aortic intima, the levels of blood lipid and pro-inflammatory factors and the immobility time of FST and TST decreased significantly (P < 0.01), the sucrose preference rate of SPT significantly increased (P < 0.01), the ratio of p-NF-κB/NF-κB decreased significantly (P < 0.01), and the ratios of p-GSK3β(Ser9)/GSK3β and p-CREB(Ser133)/CREB increased significantly (P < 0.05, P < 0.01).  CONCLUSION  Tanshinone ⅡA has a significant effect against coronary heart disease with comorbid depression in ApoE-/- mice, and its mechanism may be related to the regulation of GSK3β, and further activation of NF-κB and CREB.

     

    • FullText(HTML)
  • loading
    • References(26)
  • [1]
    CARNEY RM, FREEDLAND KE. Depression, mortality, and medical morbidity in patients with coronary heart disease[J]. Biol Psychiatry, 2003, 54(3): 241-247. doi: 10.1016/S0006-3223(03)00111-2
    [2]
    THOMBS BD, BASS EB, FORD DE, et al. Prevalence of depression in survivors of acute myocardial infarction[J]. J Gen Intern Med, 2006, 21(1): 30-38. doi: 10.1111/j.1525-1497.2005.00269.x
    [3]
    RUO B, RUMSFELD JS, PIPKIN S, et al. Relation between depressive symptoms and treadmill exercise capacity in the heart and soul study[J]. Am J Cardiol, 2004, 94(1): 96-99. doi: 10.1016/j.amjcard.2004.03.035
    [4]
    MALLIK S, KRUMHOLZ HM, LIN ZQ, et al. Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery[J]. Circulation, 2005, 111(3): 271-277. doi: 10.1161/01.CIR.0000152102.29293.D7
    [5]
    MOUSSAVI S, CHATTERJI S, VERDES E, et al. Depression, chronic diseases, and decrements in health: Results from the World Health Surveys[J]. Lancet, 2007, 370(9590): 851-858. doi: 10.1016/S0140-6736(07)61415-9
    [6]
    NAISMITH SL, GLOZIER N, BURKE D, et al. Early intervention for cognitive decline: Is there a role for multiple medical or behavioural interventions?[J]. Early Interv Psychiatry, 2009, 3(1): 19-27. doi: 10.1111/j.1751-7893.2008.00102.x
    [7]
    O'NEIL A, SANDERSON K, OLDENBURG B. Depression as a predictor of work resumption following myocardial infarction (MI): A review of recent research evidence[J]. Health Qual Life Outcomes, 2010, 8: 95. doi: 10.1186/1477-7525-8-95
    [8]
    ALEXANDER RW. Inflammation and coronary artery disease[J]. N Engl J Med, 1994, 331(7): 468-469. doi: 10.1056/NEJM199408183310709
    [9]
    TALEB S. Inflammation in atherosclerosis[J]. Arch Cardiovasc Dis, 2016, 109(12): 708-715. doi: 10.1016/j.acvd.2016.04.002
    [10]
    WIRTZ PH, VON KÄNEL R. Psychological stress, inflammation, and coronary heart disease[J]. Curr Cardiol Rep, 2017, 19(11): 111. doi: 10.1007/s11886-017-0919-x
    [11]
    VALKANOVA V, EBMEIER KP, ALLAN CL. CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies[J]. J Affect Disord, 2013, 150(3): 736-744. doi: 10.1016/j.jad.2013.06.004
    [12]
    KÖHLER CA, FREITAS TH, MAES M, et al. Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies[J]. Acta Psychiatr Scand, 2017, 135(5): 373-387. doi: 10.1111/acps.12698
    [13]
    MARTIN M, REHANI K, JOPE RS, et al. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3[J]. Nat Immunol, 2005, 6(8): 777-784. doi: 10.1038/ni1221
    [14]
    WANG HZ, BROWN J, GU Z, et al. Convergence of the mammalian target of rapamycin complex 1-and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response[J]. J Immunol, 2011, 186(9): 5217-5226. doi: 10.4049/jimmunol.1002513
    [15]
    SUN DD, SHEN M, LI JY, et al. Cardioprotective effects of tanshinone ⅡA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy[J]. Cardiovasc Diabetol, 2011, 10: 4. doi: 10.1186/1475-2840-10-4
    [16]
    TANG FT, CAO Y, WANG TQ, et al. Tanshinone ⅡA attenuates atherosclerosis in ApoE-/- mice through down-regulation of scavenger receptor expression[J]. Eur J Pharmacol, 2011, 650(1): 275-284. doi: 10.1016/j.ejphar.2010.07.038
    [17]
    WANG HQ, TONG Y, XIAO D, et al. Involvement of mTOR-related signaling in antidepressant effects of Sophoraflavanone G on chronically stressed mice[J]. Phytother Res, 2020, 34(9): 2246-2257. doi: 10.1002/ptr.6675
    [18]
    GAO J, YANG GQ, PI RB, et al. Tanshinone ⅡA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis[J]. Transl Res, 2008, 151(2): 79-87. doi: 10.1016/j.trsl.2007.11.005
    [19]
    SUN DD, WANG HC, WANG XB, et al. Tanshinone ⅡA: A new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels[J]. Eur J Pharmacol, 2008, 590(1/2/3): 317-321.
    [20]
    ZHANG Z, LAM TN, ZUO Z. Radix Puerariae: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use[J]. J Clin Pharmacol, 2013, 53(8): 787-811.
    [21]
    ZHANG Y, WEI L, SUN D, et al. Tanshinone ⅡA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats[J]. Diabetes Obes Metab, 2010, 12(4): 316-322. doi: 10.1111/j.1463-1326.2009.01166.x
    [22]
    XU M, CAO FL, ZHANG YF, et al. Tanshinone ⅡA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice[J]. Acta Pharmacol Sin, 2015, 36(2): 179-187. doi: 10.1038/aps.2014.112
    [23]
    WEN JX, CHANG YM, HUO SS, et al. Tanshinone ⅡA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation[J]. Aging, 2020, 13(1): 910-932.
    [24]
    BEUREL E, TOUPS M, NEMEROFF CB. The bidirectional relationship of depression and inflammation: Double trouble[J]. Neuron, 2020, 107(2): 234-256. doi: 10.1016/j.neuron.2020.06.002
    [25]
    SU WJ, ZHANG Y, CHEN Y, et al. NLRP3 gene knockout blocks NF-κB and MAPK signaling pathway in CUMS-induced depression mouse model[J]. Behav Brain Res, 2017, 322(Pt A): 1-8.
    [26]
    WU ZT, WANG GH, WEI YY, et al. PI3K/AKT/GSK3β/CRMP-2-mediated neuroplasticity in depression induced by stress[J]. Neuroreport, 2018, 29(15): 1256-1263. doi: 10.1097/WNR.0000000000001096
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (170) PDF downloads(25) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return